Noxopharm Ltd NOXOF
$0.05
Last Updated: May 15, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
NOXOF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Noxopharm Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Noxopharm Ltd. Stock Analysis NOXOF
United States Health Care Nano Cap Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Castle Hill, New South Wales. The company went IPO on 2016-08-09. The company is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. The company utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.
Noxopharm Ltd (NOXOF) Chart
Financial Metrics & Statements of Noxopharm Ltd (NOXOF)
FAQ's for Noxopharm Ltd (NOXOF)
- As of August 2026, Noxopharm Ltd NOXOF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Noxopharm Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Noxopharm Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Noxopharm Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Noxopharm Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Noxopharm Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Noxopharm Ltd (NOXOF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
